Current UK regulatory position includes: Warnings and precautions regarding thyroid C-cell tumours based on animal data, with acknowledgement that human relevance is uncertain Advice regarding pancreatitis risk, with recommendations to discontinue if acute pancreatitis is suspected and not to restart if confirmed No restrictions based on general cancer risk, as human evidence does not support an increased overall malignancy risk Monitoring for gallbladder disease, which has been associated with GLP-1 receptor agonist use The Summary of Product Characteristics (SmPC) for each GLP-1 medicine includes detailed safety information that healthcare professionals should review before prescribing
The feelings change . Sorry to interrupt you, you're saying that it wasn't until you had the injection that you realize that you identified
With an oral form of Wegovy arriving in 2026, patients now face a choice between a daily tablet taken on a strict empty stomach and an injection that skips the gut entirely
Nutrients, 11(10), 2412
It is a frustrating cycle: the liver needs glutathione to fight the stress caused by fat, but the stress itself depletes the glutathione it has
It regulates blood sugar by enhancing insulin secretion and slowing gastric emptying, thereby reducing appetite
